7 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #Antidiabetic #Medications ... #SideEffects #Table ... #Endocrinology ... #Pharmacology #Management
Summary of Pharmacology for Select Proposed COVID-19 Treatments

#Pharmacology #Dosing #Table #COVID19 #Coronavirus #SARSCOV2 #Medications #JAMA
Select Proposed COVID ... #Pharmacology #Dosing ... #Table #COVID19 ... #Coronavirus #SARSCOV2 ... #Medications #JAMA
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... #medications #table ... #comparison #management ... #endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... pharmacotherapy #table ... #comparison #management ... #medications #diabetes ... #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... different than other medications ... #Pharmacology #Management ... #Diabetes #DM2 ... #Endocrinology
COVID-19 Intubation Checklist

Personal protective equipment (PPE)
 • Standard PPE
   • N95 or PAPR.
COVID-19 Intubation ... Medications & pre-planned ... Care @iBookCC #COVID19 ... Intubation #Checklist #SARSCoV2 ... #Management #CriticalCare
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... drug to remain stable ... take any other medications ... #semaglutide #Diabetes ... #Pharmacology #Endocrinology